Echo Therapeutics, Inc. (ECTE) - Financial and Strategic SWOT Analysis Review

GlobalData, September 2011, Pages: 44

Echo Therapeutics, Inc. (ECTE) - Financial and Strategic SWOT Analysis Review

Summary

Echo Therapeutics, Inc. (Echo Therapeutics) is a medical device and specialty pharmaceuticals company. It engages in developing non-invasive (needle-free), wireless, transdermal continuous glucose monitoring (tCGM) system for diabetes and pharmaceutical products. The company uses its AzoneTS skin penetration technology to develop different transdermal reformulations of pharmaceutical products previously approved by the FDA. It also focuses on developing Prelude SkinPrep System (Prelude) as a platform technology to allow painless skin permeation that would enable two applications, analyte extraction and needle-free drug delivery. The company is in the process of developing Prelude as a transdermal skin permeation device for its Symphony tCGM System to improve the flow of interstitial fluids and molecules across the protective membrane of the stratum corneum, the outmost protective layer of the skin. Echo Therapeutics is headquartered in Philadelphia, Pennsylvania, the US.

Echo Therapeutics, Inc. Key Recent Developments

Sep 20, 2011: Echo Therapeutics To Present At JMP Securities Healthcare Conference
Sep 15, 2011: Echo Therapeutics Receives Registered Trademarks For Symphony And Prelude
Aug 12, 2011: Echo Therapeutics Reports Total Revenues Of $158,520 In Q2 2011
Aug 08

This comprehensive SWOT profile of Echo Therapeutics, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
Echo Therapeutics, Inc. - Key Facts
Echo Therapeutics, Inc. - Key Employees
Echo Therapeutics, Inc. - Key Employee Biographies
Echo Therapeutics, Inc. - Major Products and Services
Echo Therapeutics, Inc. - Pharmaceutical Pipeline Products Data
Echo Therapeutics, Inc., Pipeline Products by Therapy Area
Echo Therapeutics, Inc., Pipeline Products by Development Phase
Echo Therapeutics, Inc. - Medical Equipment Pipeline Products Data
Echo Therapeutics, Inc. Pipeline Products by Equipment Type
Echo Therapeutics, Inc. Pipeline Products by Development Stage
Echo Therapeutics, Inc. - History
Echo Therapeutics, Inc. - Company Statement
Echo Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Echo Therapeutics, Inc. - Business Description
Echo Therapeutics, Inc. - SWOT Analysis
SWOT Analysis - Overview
Echo Therapeutics, Inc. - Strengths
Strength - Innovative technologies
Strength - Symphony tCGM System
Strength - Strong Focus on Research & Development
Weakness - History of Operating Losses
Weakness - Dependence on the third-party manufacturers
Opportunity - Growing Diabetes
Opportunity - Strategic partnerships
Opportunity - Changing Demographics
Threat - Uncertain R&D outcome
Threat - Risks related to regulatory approvals
Threat - Healthcare Reform Measures
Threat - Competitive Environment
Echo Therapeutics, Inc. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Echo Therapeutics, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
Echo Therapeutics, Inc., Medical Equipment, Deals By Type, 2005 to YTD 2011
Echo Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Echo Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Echo Therapeutics, Inc., Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 15, 2011: Echo Therapeutics Receives Registered Trademarks For Symphony And Prelude
Aug 12, 2011: Echo Therapeutics Reports Total Revenues Of $158,520 In Q2 2011
Aug 08, 2011: Echo Therapeutics Announces Multiple Patents And Trademark Grants
Aug 02, 2011: Echo Therapeutics Appoints Marshall Deweese To Management Team
Jun 28, 2011: Echo Therapeutics Announces NASDAQ Listing
May 16, 2011: Echo Therapeutics Appoints Christopher Schnittker As CFO
May 16, 2011: Echo Therapeutics Reports Net Loss Of $6.6m For Q1 2011
May 05, 2011: Echo Therapeutics Expands Into New Headquarters In Philadelphia
Mar 22, 2011: Echo Therapeutics Announces Management Appointments
Mar 18, 2011: Echo Therapeutics Reports 2010 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Echo Therapeutics, Inc., Key Facts
Echo Therapeutics, Inc., Key Employees
Echo Therapeutics, Inc., Key Employee Biographies
Echo Therapeutics, Inc., Major Products and Services
Echo Therapeutics, Inc., Number of Pipeline Products by Therapy Area
Echo Therapeutics, Inc., Number of Pipeline Products by Development Stage
Echo Therapeutics, Inc., Pipeline Products By Therapy Area and Development Phase
Echo Therapeutics, Inc. Number of Pipeline Products by Equipment Type
Echo Therapeutics, Inc. Pipeline Products by Equipment Type
Echo Therapeutics, Inc. Number of Pipeline Products by Development Stage
Echo Therapeutics, Inc. Pipeline Products by Development Stage
Echo Therapeutics, Inc., History
Echo Therapeutics, Inc., Subsidiaries
Echo Therapeutics, Inc., Key Competitors
Echo Therapeutics, Inc., Ratios based on current share price
Echo Therapeutics, Inc., Annual Ratios
Echo Therapeutics, Inc., Interim Ratios
Echo Therapeutics, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
Echo Therapeutics, Inc., Medical Equipment, Deals By Type, 2005 to YTD 2011
Echo Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Echo Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
Echo Therapeutics, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Echo Therapeutics, Inc., Pipeline Products by Therapy Area
Echo Therapeutics, Inc., Pipeline Products by Development Phase
Echo Therapeutics, Inc. Pipeline Products by Equipment Type
Echo Therapeutics, Inc. Pipeline Products by Development Stage
Echo Therapeutics, Inc., Performance Chart (2006 - 2010)
Echo Therapeutics, Inc., Ratio Charts
Echo Therapeutics, Inc., Medical Equipment, Deals By Year, 2005 to YTD 2011
Echo Therapeutics, Inc., Medical Equipment, Deals by Type, 2005 to YTD 2011
Echo Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
Echo Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011

Cygnus Inc
Medtronic, Inc.
Edwards Lifesciences Corporation
Luminous Medical, Inc.
DexCom, Inc.

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Scientific Games Corporation - Company Analysis
• Ixia - Company Analysis
• eBay - Strong Execution
• Amazon - Point of Realization in 2013?
• SunGard - Profile - US
• Insight into Samsung Electronics' Notebook PC Business Model
• ON Vendor Profile: Ciena